Author:
Brüggemann Bernd,Elgeti H.
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Brunot A, Lachaux B, Sontag H et al.: Pharmaco–epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia. Encephale 28, 129–138 (2002)
2. Clark RE, Bartels SJ, Mellmann T. A., Peacock WJ.: Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull 28, 75–84 (2002)
3. de las Cuevas C, Sanz EJ.: Polypharmacy in psychiatric practice in the Canary Islands. BMC Psychiatry 4, 18 (2004)
4. Edlinger M, Hausmann A, Kemmler G, Kurz M, Kurzthaler I, Walch T, Walpoth M, Fleischhacker WW.: Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period. Schizophr Res 77, 25–34 (2005)
5. Ereshefsky L. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic. J Clin Psychiatry 1999; 60 Suppl 10:20–30.